Green Cross Medical Science Corporation (KOSDAQ:142280)

South Korea flag South Korea · Delayed Price · Currency is KRW
3,520.00
-115.00 (-3.16%)
At close: Mar 9, 2026
-7.85%
Market Cap 76.53B
Revenue (ttm) 111.12B
Net Income (ttm) 5.66B
Shares Out 21.74M
EPS (ttm) 150.83
PE Ratio 23.34
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 70,247
Average Volume 84,684
Open 3,615.00
Previous Close 3,635.00
Day's Range 3,415.00 - 3,615.00
52-Week Range 3,200.00 - 5,090.00
Beta 0.50
RSI 39.73
Earnings Date Mar 17, 2026

About KOSDAQ:142280

Green Cross Medical Science Corporation manufactures and sells diagnostic reagents and medical devices in South Korea and internationally. The company offers immunology diagnostic reagents. It also provides COVID-19 kit; blood glucose monitoring system; HbA1c test machine; and Gcare LIPID and LIPID printer. Green Cross Medical Science Corporation was founded in 1972 and is headquartered in Yongin-Si, South Korea. [Read more]

Industry In Vitro and In Vivo Diagnostic Substances
Founded 1972
Employees 122
Stock Exchange KOSDAQ
Ticker Symbol 142280
Full Company Profile

Financial Performance

In 2024, KOSDAQ:142280's revenue was 103.85 billion, an increase of 10.47% compared to the previous year's 94.01 billion. Earnings were 3.58 billion, an increase of 99.25%.

Financial Statements

News

There is no news available yet.